Failure of alemtuzumab therapy in three patients with MOG antibody associated disease

Overview of attention for article published in BMC Neurology, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 8,021 followers.

RT @MasturaMonif: If you have a patient with suspected MS not responding to Alemtuzumab or Natalizumab check their #antiMOG antibodies. W…

Please, please, dont after treat¡¡¡ before start treatment and after neurological exam...

New article: Failure of alemtuzumab therapy in three patients with MOG antibody associated disease https://t.co/l0nf9QNktm #MS #multiplesclerosis #neurology https://t.co/LZ04NgePSw

RT @MasturaMonif: If you have a patient with suspected MS not responding to Alemtuzumab or Natalizumab check their #antiMOG antibodies. W…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.